Literature DB >> 31598678

miR-146a promoted breast cancer proliferation and invasion by regulating NM23-H1.

Jun Chen1, Qiang Jiang2, Xue-Qin Jiang1, De-Quan Li1, Xiao-Cheng Jiang1, Xiao-Bo Wu1, Ya-Li Cao1.   

Abstract

The study aimed to investigate the regulatory effect of miR-146a in proliferation, invasion and migration of breast cancer and its possible mechanism via NM23-H1. The expression levels of miR-146a in breast cancer with different pathological classification were significantly increased, while the expression levels of NM23-H1 were significantly decreased, which were closely correlated. Double luciferase reporter gene was used to verify the target regulatory relationship between miR-146 and NM23-H1 on a human breast cancer cell line. miR-146a was closely related to the proliferation and metastasis of breast cancer. miR-146a also promoted the growth of breast cancer in vivo via targeting NM23-H1. In conclusion, miR-146 can promote the proliferation and invasion of breast cancer by targeting NM23-H1.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  Hsa-miR-146a; breast cancer; invasion; NM23-H1; proliferation

Mesh:

Substances:

Year:  2020        PMID: 31598678     DOI: 10.1093/jb/mvz079

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness.

Authors:  Farzaneh Darbeheshti; Sepideh Kadkhoda; Mahsa Keshavarz-Fathi; Sepideh Razi; Afshin Bahramy; Yaser Mansoori; Nima Rezaei
Journal:  BMC Cancer       Date:  2022-06-17       Impact factor: 4.638

2.  Correlation between nm23-H_1 expression and transvaginal color Doppler ultrasound performance after radiotherapy for cervical cancer.

Authors:  Shu Guo; Li Liu; Ying Li; Hao Shi; A-Ni Cong
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

Review 3.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  miR-146a Overexpression in Oral Squamous Cell Carcinoma Potentiates Cancer Cell Migration and Invasion Possibly via Targeting HTT.

Authors:  Liping Wang; Yunxin Chen; Yongyong Yan; Xueqi Guo; Ying Fang; Yucheng Su; Lijing Wang; Janak L Pathak; Linhu Ge
Journal:  Front Oncol       Date:  2020-11-13       Impact factor: 6.244

5.  CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.

Authors:  Ka Ming Wong; Jiaxing Song; Yung H Wong
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.

Authors:  Jianjun Wang; Kunxian Yang; Junyu Cao; Li Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Prognostic and clinicopathological significance of nm23-H1 expression in non-small cell lung cancer: A meta-analysis.

Authors:  Dailong Li; Wanqiang Li; Cheng Tian; Yaqi Pang; Lu Xu; Yuke Wang; Xinhua Xu
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

8.  Integrated Transcriptome and Proteome Analyses Reveal the Regulatory Role of miR-146a in Human Limbal Epithelium via Notch Signaling.

Authors:  Adam J Poe; Mangesh Kulkarni; Aleksandra Leszczynska; Jie Tang; Ruchi Shah; Yasaman Jami-Alahmadi; Jason Wang; Andrei A Kramerov; James Wohlschlegel; Vasu Punj; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Cells       Date:  2020-09-26       Impact factor: 6.600

9.  Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.

Authors:  Aiqin Fu; Ze Yu; Enning Zhang; Jijie Song
Journal:  Thorac Cancer       Date:  2021-08-24       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.